首页 › 基金 › Tetragon Partners GP Ltd › KRYS
Tetragon Partners GP Ltd 对 KRYS 的持仓历史
KRYSTAL BIOTECH INC · 医疗保健
Tetragon Partners GP Ltd 在 Q3 2026 的 13F 申报中披露持有 KRYS(KRYSTAL BIOTECH INC)19,668 股,市值约 US$6.5M,约占其申报组合的 0.89%,在其申报持仓中市值排名第 21 位。 Tetragon Partners GP Ltd 最近 5 个申报季度中有 5 个季度披露了 KRYS 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Tetragon Partners GP Ltd 对 KRYS 的持仓演变
Tetragon Partners GP Ltd 于 Q3 2025 首次披露 KRYS 持仓:4,870 股(约 US$860K)。 该持仓在 Q2 2026 达到峰值 19,668 股,市值约 US$7.3M。 在 5 次申报中,Tetragon Partners GP Ltd 2 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 19,668 股、市值约 US$6.5M。 持仓曾出现大幅变动:Q4 2025 增持约 143% (随后一个季度股价上涨 5%)、Q1 2026 增持约 66% (随后一个季度股价上涨 44%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 4.87K | $859.70K | 新进 |
| Q4 2025 | 11.81K | $2.91M | 增持 |
| Q1 2026 | 19.67K | $5.08M | 增持 |
| Q2 2026 | 19.67K | $7.31M | 持有 |
| Q3 2026 | 19.67K | $6.54M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KRYS 与 13F 数据
KRYS(KRYSTAL BIOTECH INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 KRYS,申报仓位最大的包括:Avoro Capital Advisors LLC (US$960.7M), Soleus Capital Management, L.P. (US$349.1M), Redmile Group, LLC (US$234.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KRYS 的基金
- Avoro Capital Advisors LLC 2.89M 股 · $960.73M · Q3 2026
- Soleus Capital Management, L.P. 939.25K 股 · $349.09M · Q2 2026
- Redmile Group, LLC 632.00K 股 · $234.90M · Q2 2026
- Hood River Capital Management LLC 671.99K 股 · $223.48M · Q3 2026
- Frazier Life Sciences Management, L.P. 481.31K 股 · $178.89M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 520.92K 股 · $173.24M · Q3 2026
- BRAIDWELL LP 128.97K 股 · $47.94M · Q2 2026
更多关于 Tetragon Partners GP Ltd
常见问题
How long has Tetragon Partners GP Ltd held KRYS?
Tetragon Partners GP Ltd has disclosed KRYS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Tetragon Partners GP Ltd's current position in KRYS?
As of Q3 2026, Tetragon Partners GP Ltd holds 19.67K shares of KRYS (KRYSTAL BIOTECH INC), valued at $6.54M, representing 0.89% of its reported portfolio and ranking #21.
Has Tetragon Partners GP Ltd been buying or selling KRYS?
In the latest 13F filing (Q3 2026), Tetragon Partners GP Ltd held unchanged its position in KRYS. The position peaked in Q2 2026 at 19.67K shares.
Which other funds hold KRYS?
Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Redmile Group, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.